Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378611283> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4378611283 endingPage "A312" @default.
- W4378611283 startingPage "A311" @default.
- W4378611283 abstract "Abstract Introduction Tonic motor activation (TOMAC) is a noninvasive medical device therapy that has been shown to reduce symptoms of refractory restless legs syndrome (RLS). Here, we evaluated the effects of TOMAC on subjective sleep quality. Methods One hundred and thirty-three adults with primary moderate-severe refractory RLS were 1:1 randomized to TOMAC or sham control for 4 weeks. Participants were instructed to self-administer a 30-minute TOMAC session bilaterally over the head of the fibula to electrically stimulate the peroneal nerve whenever RLS symptoms presented. Sleep quality was assessed through prespecified analysis of changes to Medical Outcomes Study Sleep Scale (MOS-Sleep) Sleep Problems Index I (MOS-I) and II (MOS-II) scores from baseline to Week 4. Post hoc t-tests were conducted on each MOS-Sleep item included in the MOS-I or MOS-II. Results MOS-I score changed by -11.8 points (48.5 to 36.7) for TOMAC and -2.8 points for sham (44.5 to 41.7), a difference of -9.0 points (p< 0.001). MOS-II score changed by -13.7 points (52.5 to 38.9) for TOMAC and -4.0 points for sham (48.3 to 44.3), a difference of -9.7 points (p< 0.001), which exceeds the proposed minimal clinically important difference (MCID) of 6 points. Post hoc analysis demonstrated statistically significant reductions in trouble falling asleep (item #7; -34.0% for TOMAC vs. -5.8% for sham; p< 0.01) and trouble staying awake during the day (item #9; -33.6% for TOMAC vs. -2.1% for sham; p< 0.05), which exceeded the standard MCID threshold of 30% relative to baseline. Conclusion For adults with refractory RLS, TOMAC improved subjective sleep quality, sleep latency, and daytime somnolence relative to sham control. Each of these improvements represented clinically important improvements. These data demonstrate that TOMAC can provide meaningful improvements to sleep quality and daytime functioning for patients with refractory RLS. Support (if any) Funding was provided by Noctrix Health, Inc." @default.
- W4378611283 created "2023-05-29" @default.
- W4378611283 creator A5011434321 @default.
- W4378611283 creator A5024730777 @default.
- W4378611283 creator A5029241873 @default.
- W4378611283 creator A5041044072 @default.
- W4378611283 creator A5082868877 @default.
- W4378611283 creator A5084367532 @default.
- W4378611283 creator A5086569506 @default.
- W4378611283 creator A5090559311 @default.
- W4378611283 date "2023-05-01" @default.
- W4378611283 modified "2023-10-16" @default.
- W4378611283 title "0710 Effects of tonic motor activation (TOMAC) therapy on sleep quality for refractory restless legs syndrome" @default.
- W4378611283 doi "https://doi.org/10.1093/sleep/zsad077.0710" @default.
- W4378611283 hasPublicationYear "2023" @default.
- W4378611283 type Work @default.
- W4378611283 citedByCount "0" @default.
- W4378611283 crossrefType "journal-article" @default.
- W4378611283 hasAuthorship W4378611283A5011434321 @default.
- W4378611283 hasAuthorship W4378611283A5024730777 @default.
- W4378611283 hasAuthorship W4378611283A5029241873 @default.
- W4378611283 hasAuthorship W4378611283A5041044072 @default.
- W4378611283 hasAuthorship W4378611283A5082868877 @default.
- W4378611283 hasAuthorship W4378611283A5084367532 @default.
- W4378611283 hasAuthorship W4378611283A5086569506 @default.
- W4378611283 hasAuthorship W4378611283A5090559311 @default.
- W4378611283 hasBestOaLocation W43786112831 @default.
- W4378611283 hasConcept C118552586 @default.
- W4378611283 hasConcept C121332964 @default.
- W4378611283 hasConcept C126322002 @default.
- W4378611283 hasConcept C127573956 @default.
- W4378611283 hasConcept C142424586 @default.
- W4378611283 hasConcept C16568411 @default.
- W4378611283 hasConcept C1862650 @default.
- W4378611283 hasConcept C2776750294 @default.
- W4378611283 hasConcept C42219234 @default.
- W4378611283 hasConcept C67761136 @default.
- W4378611283 hasConcept C71924100 @default.
- W4378611283 hasConcept C87355193 @default.
- W4378611283 hasConceptScore W4378611283C118552586 @default.
- W4378611283 hasConceptScore W4378611283C121332964 @default.
- W4378611283 hasConceptScore W4378611283C126322002 @default.
- W4378611283 hasConceptScore W4378611283C127573956 @default.
- W4378611283 hasConceptScore W4378611283C142424586 @default.
- W4378611283 hasConceptScore W4378611283C16568411 @default.
- W4378611283 hasConceptScore W4378611283C1862650 @default.
- W4378611283 hasConceptScore W4378611283C2776750294 @default.
- W4378611283 hasConceptScore W4378611283C42219234 @default.
- W4378611283 hasConceptScore W4378611283C67761136 @default.
- W4378611283 hasConceptScore W4378611283C71924100 @default.
- W4378611283 hasConceptScore W4378611283C87355193 @default.
- W4378611283 hasIssue "Supplement_1" @default.
- W4378611283 hasLocation W43786112831 @default.
- W4378611283 hasOpenAccess W4378611283 @default.
- W4378611283 hasPrimaryLocation W43786112831 @default.
- W4378611283 hasRelatedWork W2170431845 @default.
- W4378611283 hasRelatedWork W2351796763 @default.
- W4378611283 hasRelatedWork W2403502999 @default.
- W4378611283 hasRelatedWork W2567738959 @default.
- W4378611283 hasRelatedWork W2699314556 @default.
- W4378611283 hasRelatedWork W2805788151 @default.
- W4378611283 hasRelatedWork W2923882796 @default.
- W4378611283 hasRelatedWork W2954318774 @default.
- W4378611283 hasRelatedWork W4297834875 @default.
- W4378611283 hasRelatedWork W4366141624 @default.
- W4378611283 hasVolume "46" @default.
- W4378611283 isParatext "false" @default.
- W4378611283 isRetracted "false" @default.
- W4378611283 workType "article" @default.